‘Backed by Science’ — But What Kind of Science?

Everyone says it is backed by science. But that phrase does not tell you nearly enough. A product page can cite a petri-dish experiment, a rodent injury model, an uncontrolled human observation, and a randomized clinical trial with the same confidence. Those documents are not interchangeable.

Science is not one layer

A cell study can be beautifully designed and still only show that a pathway changes in isolated cells. A mouse study can be rigorous and still fail in humans. A human case report can be true and still not prove cause. A randomized controlled trial can be strong and still apply only to the people, endpoint, dose, and duration studied.

The marketing problem

Peptide marketing often benefits from ambiguity. If a study shows faster wound closure in a rodent model, the marketing copy may imply recovery benefits in people. If a compound changes a biomarker, the copy may imply a clinical outcome. If a pathway is associated with aging, the copy may imply anti-aging efficacy. The claim becomes stronger as it travels farther from the paper.

The reader's question

The best response is not to reject all early science. It is to ask: what kind of science? Was the study done in cells, animals, or humans? Was there a control group? How many subjects were included? What endpoint was measured? Was the result replicated? Does the claim match the endpoint?

The more confident the claim, the higher the evidence bar should be.

'Backed by science' should be the beginning of the conversation, not the end. A serious publication names the evidence layer before drawing the conclusion.